Heard of LASA? Learn more about Look-Alike, Sound-Alike medicines

With deceptively similar drug names, these medicines heighten the chances of medication errors, endangering patient safety, particularly in low- and middle-income regions.

Published Oct 30, 2024 | 3:08 PMUpdated Oct 30, 2024 | 3:08 PM

Dr Parth Sharma, a community physician and public health researcher, delves into the serious risks associated with Look-Alike, Sound-Alike (LASA) medicines in India.

With deceptively similar drug names, these medicines heighten the chances of medication errors, endangering patient safety, particularly in low- and middle-income regions.

Drawing from his article in The Lancet, Dr Sharma explains strategies to reduce these risks and create safer practices within the pharmaceutical industry. Discover how healthcare providers, patients, and policymakers can join forces to avoid these critical errors

Interview: Risks of Look-Alike, Sound-Alike medicines in India, how to prevent medication errors

journalist
Share
Follow us